Literature DB >> 20634072

North Star Ambulatory Assessment, 6-minute walk test and timed items in ambulant boys with Duchenne muscular dystrophy.

Elena Mazzone1, Diego Martinelli, Angela Berardinelli, Sonia Messina, Adele D'Amico, Gessica Vasco, Marion Main, Luca Doglio, Luisa Politano, Filippo Cavallaro, Silvia Frosini, Luca Bello, Adelina Carlesi, Anna Maria Bonetti, Elisabetta Zucchini, Roberto De Sanctis, Marianna Scutifero, Flaviana Bianco, Francesca Rossi, Maria Chiara Motta, Annalisa Sacco, Maria Alice Donati, Tiziana Mongini, Antonella Pini, Roberta Battini, Elena Pegoraro, Marika Pane, Elisabetta Pasquini, Claudio Bruno, Giuseppe Vita, Chiara de Waure, Enrico Bertini, Eugenio Mercuri.   

Abstract

The North Star Ambulatory Assessment is a functional scale specifically designed for ambulant boys affected by Duchenne muscular dystrophy (DMD). Recently the 6-minute walk test has also been used as an outcome measure in trials in DMD. The aim of our study was to assess a large cohort of ambulant boys affected by DMD using both North Star Assessment and 6-minute walk test. More specifically, we wished to establish the spectrum of findings for each measure and their correlation. This is a prospective multicentric study involving 10 centers. The cohort included 112 ambulant DMD boys of age ranging between 4.10 and 17 years (mean 8.18±2.3 DS). Ninety-one of the 112 were on steroids: 37/91 on intermittent and 54/91 on daily regimen. The scores on the North Star assessment ranged from 6/34 to 34/34. The distance on the 6-minute walk test ranged from 127 to 560.6 m. The time to walk 10 m was between 3 and 15 s. The time to rise from the floor ranged from 1 to 27.5 s. Some patients were unable to rise from the floor. As expected the results changed with age and were overall better in children treated with daily steroids. The North Star assessment had a moderate to good correlation with 6-minute walk test and with timed rising from floor but less with 10 m timed walk/run test. The 6-minute walk test in contrast had better correlation with 10 m timed walk/run test than with timed rising from floor. These findings suggest that a combination of these outcome measures can be effectively used in ambulant DMD boys and will provide information on different aspects of motor function, that may not be captured using a single measure.
Copyright © 2010. Published by Elsevier B.V.

Entities:  

Mesh:

Year:  2010        PMID: 20634072     DOI: 10.1016/j.nmd.2010.06.014

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  75 in total

1.  Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study.

Authors:  Luca Bello; Heather Gordish-Dressman; Lauren P Morgenroth; Erik K Henricson; Tina Duong; Eric P Hoffman; Avital Cnaan; Craig M McDonald
Journal:  Neurology       Date:  2015-08-26       Impact factor: 9.910

2.  Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.

Authors:  Michele Gaeta; Sonia Messina; Achille Mileto; Gian Luca Vita; Giorgio Ascenti; Sergio Vinci; Antonio Bottari; Giuseppe Vita; Nicola Settineri; Daniele Bruschetta; Sergio Racchiusa; Fabio Minutoli
Journal:  Skeletal Radiol       Date:  2011-11-10       Impact factor: 2.199

3.  Quantitative Ultrasound Assessment of Duchenne Muscular Dystrophy Using Edge Detection Analysis.

Authors:  Sisir Koppaka; Irina Shklyar; Seward B Rutkove; Basil T Darras; Brian W Anthony; Craig M Zaidman; Jim S Wu
Journal:  J Ultrasound Med       Date:  2016-07-14       Impact factor: 2.153

4.  Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy.

Authors:  Luca Bello; Luisa Piva; Andrea Barp; Antonella Taglia; Esther Picillo; Gessica Vasco; Marika Pane; Stefano C Previtali; Yvan Torrente; Elisabetta Gazzerro; Maria Chiara Motta; Gaetano S Grieco; Sara Napolitano; Francesca Magri; Adele D'Amico; Guja Astrea; Sonia Messina; Maria Sframeli; Gian Luca Vita; Patrizia Boffi; Tiziana Mongini; Alessandra Ferlini; Francesca Gualandi; Gianni Soraru'; Mario Ermani; Giuseppe Vita; Roberta Battini; Enrico Bertini; Giacomo P Comi; Angela Berardinelli; Carlo Minetti; Claudio Bruno; Eugenio Mercuri; Luisa Politano; Corrado Angelini; Eric P Hoffman; Elena Pegoraro
Journal:  Neurology       Date:  2012-06-27       Impact factor: 9.910

5.  A Simple and Low-cost Assay for Measuring Ambulation in Mouse Models of Muscular Dystrophy.

Authors:  Elizabeth M Gibbs; Rachelle H Crosbie-Watson
Journal:  J Vis Exp       Date:  2017-12-29       Impact factor: 1.355

6.  Loss of electrical anisotropy is an unrecognized feature of dystrophic muscle that may serve as a convenient index of disease status.

Authors:  Seward B Rutkove; Jim S Wu; Craig Zaidman; Kush Kapur; Sung Yim; Amy Pasternak; Lavanya Madabusi; Heather Szelag; Tim Harrington; Jia Li; Adam Pacheck; Basil T Darras
Journal:  Clin Neurophysiol       Date:  2016-10-13       Impact factor: 3.708

7.  Physical function and mobility in children with congenital myotonic dystrophy.

Authors:  Evan M Pucillo; Deanna L Dibella; Man Hung; Jerry Bounsanga; Becky Crockett; Melissa Dixon; Russell J Butterfield; Craig Campbell; Nicholas E Johnson
Journal:  Muscle Nerve       Date:  2017-02-13       Impact factor: 3.217

8.  English cross-cultural translation and validation of the neuromuscular score: a system for motor function classification in patients with neuromuscular diseases.

Authors:  Carole Vuillerot; Katherine G Meilleur; Minal Jain; Melissa Waite; Tianxia Wu; Melody Linton; Jahannaz Datsgir; Sandra Donkervoort; Meganne E Leach; Anne Rutkowski; Pascal Rippert; Christine Payan; Jean Iwaz; Dalil Hamroun; Carole Bérard; Isabelle Poirot; Carsten G Bönnemann
Journal:  Arch Phys Med Rehabil       Date:  2014-05-24       Impact factor: 3.966

9.  Beyond ambulation: Measuring physical activity in youth with Duchenne muscular dystrophy.

Authors:  Mary Killian; Maciej S Buchowski; Thomas Donnelly; W Bryan Burnette; Larry W Markham; James C Slaughter; Meng Xu; Kimberly Crum; Bruce M Damon; Jonathan H Soslow
Journal:  Neuromuscul Disord       Date:  2020-02-20       Impact factor: 4.296

10.  The cooperative international neuromuscular research group Duchenne natural history study--a longitudinal investigation in the era of glucocorticoid therapy: design of protocol and the methods used.

Authors:  Craig M McDonald; Erik K Henricson; R Ted Abresch; Jay J Han; Diana M Escolar; Julaine M Florence; Tina Duong; Adrienne Arrieta; Paula R Clemens; Eric P Hoffman; Avital Cnaan
Journal:  Muscle Nerve       Date:  2013-05-16       Impact factor: 3.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.